- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Weekly Roundup: February 1-5, 2021
In case you missed it, some of this week’s featured content includes a new podcast episode on the popularity of TikTok for dermatologists, FDA approvals for Soliton’s RAP device for cellulite and Galderma’s Restylane Defyne for chin augmentation, enrollment commencement for a food supplement and skin inflammation study, plus more.
POLL: Has your practice seen a rise in aesthetic procedures since the start of the pandemic?
The Mainstream Patient: February 1, 2021
This week’s edition of The Mainstream Patient features stories on sunscreen expiration, the link between dairy and acne, the skin barrier, how to manage retinization, plus more.
FDA Clears Soliton’s RAP Device for Cellulite
Soliton announced the FDA has cleared its Rapid Acoustic Pulse (RAP) device for short-term improvement in appearance of cellulite.
Enrollment Begins for Food Supplement, Skin Inflammation Study
A proprietary food supplement designed to balance the gut microbiome and target the over production of skin cells will be examined in an upcoming consumer study that has recently announced participant enrollment.
FDA Approves Restylane Defyne for Chin Augmentation
Galderma announces the FDA-approval of HA dermal filler, Restylane Defyne for use in chin augmentation.
Cosmetics and the COVID-19 Face Mask
In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, shares her tips for using cosmetics under face masks.
The Cutaneous Connection: Episode 17- TikTok and Its Influence on Dermatology
Angelo Landriscina, MD, discusses the recent rise in influence that TikTok has had over the dermatology industry.
Managing AD Pain, Long-Term Therapy Effectively
Adam Friedman, MD, FAAD, outlined his five rules to ensure an effective atopic dermatitis management plan and discussed the current treatments available.
